• Facebook
  • Youtube
  • Linkedin
  • Twitter
  • About Us
    • History
    • Leadership Team
    • Board of Directors
  • How We Work
  • Our Programs
    • Infectious Diseases
      • HIV/AIDS
      • Malaria
      • Tuberculosis
      • Hepatitis
    • Women and Children’s Health
      • Diarrhea and Pneumonia
        • Oxygen therapy
      • Maternal, Newborn, and Reproductive Health
      • Nutrition
      • Vaccines
    • Universal Health Coverage
      • Health Financing
      • Health Workforce
    • Non-Communicable Diseases
      • Cancer
      • Cervical Cancer
    • Cross-Cutting Experts
      • Market Shaping
      • Global Health Sciences
  • Where We Work
    • Africa
      • Cameroon
      • Democratic Republic of Congo
      • Ethiopia
      • Eswatini
      • Ghana
      • Kenya
      • Lesotho
      • Liberia
      • Malawi
      • Mozambique
      • Nigeria
      • Rwanda
      • Senegal
      • Sierra Leone
      • South Africa
      • Tanzania
      • Uganda
      • Zambia
      • Zimbabwe
    • Asia Pacific
      • Cambodia
      • India
      • Indonesia
      • Lao PDR
      • Myanmar
      • Papua New Guinea
      • Vietnam
    • Mesoamerica and Hispaniola
  • Resource Center
    • RFPs
    • Annual Reports
    • Financial Statements
  • Press Room
  • Blog
  • Contact
  • Join Our Team
Select Page
CHAI and Unitaid seek proposals to catalyze optimization of 2nd-line HIV treatment for children

CHAI and Unitaid seek proposals to catalyze optimization of 2nd-line HIV treatment for children

by Corina Milic | Sep 14, 2020

  Request for Proposal (RfP) for selection of generic manufacturer for development of pediatric darunavir/ritonavir (DRV/r) fixed dose combination product The Clinton Health Access Initiative, Inc. (CHAI), with funding from Unitaid, is requesting proposals to...
Early Market Access Vehicle for VISITECT® CD4 Advanced Disease Test

Early Market Access Vehicle for VISITECT® CD4 Advanced Disease Test

by Corina Milic | Apr 28, 2020

The Early Market Access Vehicle (EMAV) is the first phase of a two-phased strategy designed by Unitaid and the Clinton Health Access Initiative, Inc. (CHAI) to enable expanded access to the VISITECT® CD4 Advanced Disease test. Through the EMAV, selected implementing...
Share this...
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin
Email this to someone
email

Related Posts

  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • About Us
    • History
    • Leadership Team
    • Board of Directors
  • How We Work
    • Our Approach
    • Guiding Principles
    • Core Competencies
  • Our Programs
    • Infectious Diseases
    • Women, Newborn, and Children’s Health
    • Universal Health
    • Non-Communicable Diseases
    • Cross-Cutting Experts
  • Where We Work
  • Resource Center
    • RFPs
    • Annual Reports
    • Financial Statements
  • Press Room
    • Blog
    • Contact
    • Join Our Team
Ⓒ 2021
  • Privacy Policy
  • Terms
  • Facebook
  • Youtube
  • Linkedin
  • Twitter

Designed by Elegant Themes | Powered by WordPress